| Hernandez, Adrian |
NCT05736861: ACTIV-6: COVID-19 Study of Repurposed Medications - Arm A (Ivermectin 400) |
|
|
| Completed | 3 | 1800 | US | Ivermectin, Ivermectin Tablets, Placebo | Susanna Naggie, MD, National Center for Advancing Translational Sciences (NCATS), Vanderbilt University Medical Center | Covid19 | 03/22 | 05/22 | | |
NCT05736874: ACTIV-6: COVID-19 Study of Repurposed Medications - Arm C (Fluticasone) |
|
|
| Completed | 3 | 1407 | US | Fluticasone, Fluticasone Furoate, Placebo | Susanna Naggie, MD, National Center for Advancing Translational Sciences (NCATS), Vanderbilt University Medical Center | Covid19 | 03/22 | 05/22 | | |
NCT05890586: ACTIV-6: COVID-19 Study of Repurposed Medications - Arm B (Fluvoxamine) |
|
|
| Completed | 3 | 1331 | US | Fluvoxamine, Fluvoxamine Maleate Tablets, Placebo | Susanna Naggie, MD, National Center for Advancing Translational Sciences (NCATS), Vanderbilt University Medical Center | Covid19 | 07/22 | 09/22 | | |
NCT05894538: ACTIV-6: COVID-19 Study of Repurposed Medications - Arm D (Ivermectin 600) |
|
|
| Completed | 3 | 1459 | US | Ivermectin, Ivermectin Tablets, Placebo | Susanna Naggie, MD, National Center for Advancing Translational Sciences (NCATS), Vanderbilt University Medical Center | Covid19 | 08/22 | 10/22 | | |
| Completed | 3 | 3065 | Europe, Canada, US, RoW | Ferric Carboxymaltose, Injectafer, Ferinject, Placebo, Saline solution | American Regent, Inc., Duke Clinical Research Institute | Heart Failure, Iron-deficiency | 02/23 | 02/23 | | |
NCT05894564: ACTIV-6: COVID-19 Study of Repurposed Medications - Arm E (Fluvoxamine 100) |
|
|
| Completed | 3 | 1208 | US | Fluvoxamine, Fluvoxamine Maleate Tablets, Placebo | Susanna Naggie, MD, National Center for Advancing Translational Sciences (NCATS), Vanderbilt University Medical Center | Covid19 | 02/23 | 05/23 | | |
NCT05894577: ACTIV-6: COVID-19 Study of Repurposed Medications - Arm F (Montelukast) |
|
|
| Completed | 3 | 1453 | US | Placebo, Montelukast | Susanna Naggie, MD, National Center for Advancing Translational Sciences (NCATS), Vanderbilt University Medical Center | Covid19 | 07/23 | 01/24 | | |
NCT04885530: ACTIV-6: COVID-19 Study of Repurposed Medications |
|
|
| Completed | 3 | 10956 | US | Ivermectin, Ivermectin Tablets, Fluvoxamine, Fluvoxamine Maleate Tablets, Fluticasone, Fluticasone Furoate, Placebo, Montelukast, Metformin | Susanna Naggie, MD, National Center for Advancing Translational Sciences (NCATS), Vanderbilt University Medical Center | Covid19 | 04/24 | 04/24 | | |
NCT06042855: ACTIV-6: COVID-19 Study of Repurposed Medications - Arm G (Metformin) |
|
|
| Completed | 3 | 3214 | US | Placebo, Metformin | Susanna Naggie, MD, National Center for Advancing Translational Sciences (NCATS), Vanderbilt University Medical Center | Covid19 | 06/24 | 11/24 | | |
| Completed | N/A | 97 | US | Grocery Vouchers | Duke University, American Heart Association, Rouses Market, Instacart, Duke Clinical Research Institute, University Medical Center New Orleans - LCMC Health, Louisiana Public Health Institute | Hypertension | 10/24 | 10/24 | | |
| Completed | N/A | 200 | Europe, US | HeartLogic ON, HeartLogic OFF | Boston Scientific Corporation | Heart Failure, Congestive | 07/20 | 07/20 | | |
| VandeWeerd, Carla |
NCT05894577: ACTIV-6: COVID-19 Study of Repurposed Medications - Arm F (Montelukast) |
|
|
| Completed | 3 | 1453 | US | Placebo, Montelukast | Susanna Naggie, MD, National Center for Advancing Translational Sciences (NCATS), Vanderbilt University Medical Center | Covid19 | 07/23 | 01/24 | | |
NCT04885530: ACTIV-6: COVID-19 Study of Repurposed Medications |
|
|
| Completed | 3 | 10956 | US | Ivermectin, Ivermectin Tablets, Fluvoxamine, Fluvoxamine Maleate Tablets, Fluticasone, Fluticasone Furoate, Placebo, Montelukast, Metformin | Susanna Naggie, MD, National Center for Advancing Translational Sciences (NCATS), Vanderbilt University Medical Center | Covid19 | 04/24 | 04/24 | | |
NCT06042855: ACTIV-6: COVID-19 Study of Repurposed Medications - Arm G (Metformin) |
|
|
| Completed | 3 | 3214 | US | Placebo, Metformin | Susanna Naggie, MD, National Center for Advancing Translational Sciences (NCATS), Vanderbilt University Medical Center | Covid19 | 06/24 | 11/24 | | |
NCT02875496: Reference Database & Longitudinal Registry of the Normal and Pathological Aging Brain |
|
|
| Recruiting | N/A | 2000 | US | | ElMindA Ltd | Early Onset Alzheimer Disease, Mild Cognitive Impairment, Depression, Aging | 08/22 | 12/22 | | |
| Completed | N/A | 34 | US | Device measurements during overnight sleep and morning wake, Device measurements during overnight wake and morning sleep | Applied Cognition, University of Florida Health | Healthy | 06/23 | 06/23 | | |
| Isache, Carmen |
NCT05894577: ACTIV-6: COVID-19 Study of Repurposed Medications - Arm F (Montelukast) |
|
|
| Completed | 3 | 1453 | US | Placebo, Montelukast | Susanna Naggie, MD, National Center for Advancing Translational Sciences (NCATS), Vanderbilt University Medical Center | Covid19 | 07/23 | 01/24 | | |
NCT04885530: ACTIV-6: COVID-19 Study of Repurposed Medications |
|
|
| Completed | 3 | 10956 | US | Ivermectin, Ivermectin Tablets, Fluvoxamine, Fluvoxamine Maleate Tablets, Fluticasone, Fluticasone Furoate, Placebo, Montelukast, Metformin | Susanna Naggie, MD, National Center for Advancing Translational Sciences (NCATS), Vanderbilt University Medical Center | Covid19 | 04/24 | 04/24 | | |
NCT06042855: ACTIV-6: COVID-19 Study of Repurposed Medications - Arm G (Metformin) |
|
|
| Completed | 3 | 3214 | US | Placebo, Metformin | Susanna Naggie, MD, National Center for Advancing Translational Sciences (NCATS), Vanderbilt University Medical Center | Covid19 | 06/24 | 11/24 | | |
| Active, not recruiting | 2 | 964 | US | Experimental: Paxlovid 25 day dosing, Experimental: Paxlovid 15 day dosing, Placebo Comparator: Control | Kanecia Obie Zimmerman | Long COVID, Long Covid19 | 08/24 | 03/25 | | |
| Recruiting | 2 | 1074 | US | Modafinil, Modafinil Placebo, Solriamfetol, Solriamfetol Placebo, Melatonin, Melantonin Placebo, Tailored lighting (TL) Active, Tailored lighting (TL) Placebo | Duke University | Long COVID, Long COVID-19, Hypersomnia, Sleep Disturbance | 07/25 | 07/25 | | |
| Recruiting | N/A | 660 | US | Personalized Cardiopulmonary Rehabilitation, Structured Pacing, Education, Usual Care | Duke University, National Heart, Lung, and Blood Institute (NHLBI) | Long COVID, Long Covid19, Long Covid-19 | 10/25 | 01/26 | | |
| Roberts, Mitchell |
NCT05894577: ACTIV-6: COVID-19 Study of Repurposed Medications - Arm F (Montelukast) |
|
|
| Completed | 3 | 1453 | US | Placebo, Montelukast | Susanna Naggie, MD, National Center for Advancing Translational Sciences (NCATS), Vanderbilt University Medical Center | Covid19 | 07/23 | 01/24 | | |
NCT04885530: ACTIV-6: COVID-19 Study of Repurposed Medications |
|
|
| Completed | 3 | 10956 | US | Ivermectin, Ivermectin Tablets, Fluvoxamine, Fluvoxamine Maleate Tablets, Fluticasone, Fluticasone Furoate, Placebo, Montelukast, Metformin | Susanna Naggie, MD, National Center for Advancing Translational Sciences (NCATS), Vanderbilt University Medical Center | Covid19 | 04/24 | 04/24 | | |
NCT06042855: ACTIV-6: COVID-19 Study of Repurposed Medications - Arm G (Metformin) |
|
|
| Completed | 3 | 3214 | US | Placebo, Metformin | Susanna Naggie, MD, National Center for Advancing Translational Sciences (NCATS), Vanderbilt University Medical Center | Covid19 | 06/24 | 11/24 | | |
